A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia

A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia

Schizophrenia is a neuropsychiatric disorder characterized by various symptoms including autonomic imbalance. These disturbances involve almost all autonomic functions and might contribute to poor medication compliance, worsened quality of life and increased mortality. Therefore, it has a great impo...

Full description

Bibliographic Details
Main Authors:	Alexandra Büki, Gabriella Kekesi, Gyongyi Horvath, László Vécsei
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Series:	International Journal of Molecular Sciences
Subjects:	autonomic nervous system kynurenic acid kynurenine pathway schizophrenia
Online Access:	https://www.mdpi.com/1422-0067/22/18/10016

Similar Items

The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat
by: Gábor Nagy-Grócz, et al.
Published: (2017-06-01)

Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions
by: Ferenc Zádor, et al.
Published: (2019-10-01)

Corrigendum: The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat
by: Gábor Nagy-Grócz, et al.
Published: (2020-09-01)

Effects of inflammation on the kynurenine pathway in schizophrenia — a systematic review
by: Bruno Pedraz-Petrozzi, et al.
Published: (2020-02-01)

Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
by: Tamás Biernacki, et al.
Published: (2020-06-01)

Twelve-week physical exercise does not have a long-lasting effect on kynurenines in plasma of depressed patients
by: Millischer V, et al.
Published: (2017-03-01)

Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations
by: Livia De Picker, et al.
Published: (2020-01-01)

The Synthesis of Kynurenic Acid in Mammals: An Updated Kynurenine Aminotransferase Structural KATalogue
by: Franca Rossi, et al.
Published: (2019-02-01)

Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
by: Masaru Tanaka, et al.
Published: (2020-01-01)

Kynurenine‐3‐monooxygenase: A new direction for the treatment in different diseases
by: Yifei Lu, et al.
Published: (2020-02-01)

Systematic Review on the Involvement of the Kynurenine Pathway in Stroke: Pre-clinical and Clinical Evidence
by: Gabriela D. Colpo, et al.
Published: (2019-07-01)

The role of kynurenine pathway and kynurenic aminotransferase alleles in postpartum depression following cesarean section in Chinese women
by: Chengxuan Quan, et al.
Published: (2020-04-01)

Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus
by: Katalin Sas, et al.
Published: (2008-11-01)

The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder
by: Hongye Liu, et al.
Published: (2018-11-01)

Does the type of exercise affect tryptophan catabolism in horses?
by: W. Kędzierski, et al.
Published: (2021-11-01)

Immune Influencers in Action: Metabolites and Enzymes of the Tryptophan-Kynurenine Metabolic Pathway
by: Masaru Tanaka, et al.
Published: (2021-06-01)

Resistance Exercise Reduces Kynurenine Pathway Metabolites in Breast Cancer Patients Undergoing Radiotherapy
by: Philipp Zimmer, et al.
Published: (2019-09-01)

Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study
by: Naomichi Okamoto, et al.
Published: (2021-07-01)

Kynurenine acid - metabolism and regulation of kynurenine pathway
by: Piotr Kozłowski, et al.
Published: (2017-07-01)

Cuprizone markedly decreases kynurenic acid levels in the rodent brain tissue and plasma
by: Helga Polyák, et al.
Published: (2021-02-01)

Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway
by: Fanni A. Boros, et al.
Published: (2019-11-01)

Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome
by: Pingping Li, et al.
Published: (2020-06-01)

Natural Molecules and Neuroprotection: Kynurenic Acid, Pantethine and α-Lipoic Acid
by: Fanni Tóth, et al.
Published: (2021-01-01)

Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition
by: Robert S. Phillips, et al.
Published: (2019-02-01)

Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malaria
by: Dag Holmberg, et al.
Published: (2017-07-01)

Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine
by: Maju Mathew Koola
Published: (2016-06-01)

Effect of Tryptophan-Derived AhR Ligands, Kynurenine, Kynurenic Acid and FICZ, on Proliferation, Cell Cycle Regulation and Cell Death of Melanoma Cells—In Vitro Studies
by: Katarzyna Walczak, et al.
Published: (2020-10-01)

Early Life Stress and the Fate of Kynurenine Pathway Metabolites
by: Jeremy D. Coplan, et al.
Published: (2021-04-01)

Homeostasis Imbalance of Microglia and Astrocytes Leads to Alteration in the Metabolites of the Kynurenine Pathway in LPS-Induced Depressive-Like Mice
by: Xue Tao, et al.
Published: (2020-02-01)

Research progress of kynurenine pathway in Alzheimer's disease
by: Wei Lv, et al.
Published: (2020-05-01)

Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System
by: Cecilia Rajda, et al.
Published: (2015-08-01)

Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
by: Zsuzsanna Bohár, et al.
Published: (2015-04-01)

Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology
by: Amira Ben Afia, et al.
Published: (2021-09-01)

Kynurenine pathway metabolism and neuroinflammatory disease
by: Nady Braidy, et al.
Published: (2017-01-01)

Kynurenine pathway: the link between depressive disorders and inflammation
by: Justyna Kubacka, et al.
Published: (2020-08-01)

Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders
by: Adrian Mor, et al.
Published: (2021-06-01)

Toxoplasma gondii Effects on the Relationship of Kynurenine Pathway Metabolites to Acoustic Startle Latency in Schizophrenia vs. Control Subjects
by: Bradley D. Pearce, et al.
Published: (2020-11-01)

Kynurenines as a Novel Target for the Treatment of Malignancies
by: Adrian Mor, et al.
Published: (2021-06-01)

Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection
by: Katalin Sas, et al.
Published: (2018-01-01)

Increased Plasma Kynurenic Acid Levels are Associated with Impaired Attention/Vigilance and Social Cognition in Patients with Schizophrenia
by: Huang X, et al.
Published: (2020-01-01)

Cannot write session to /tmp/vufind_sessions/sess_vdfrjpmdcf83udjm1v5mijlah0